US Patent Issued to BASF on Feb. 24 for "Method for preparing an enantiomerically enriched form of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-ajpyrimidin-4-ium-5-olate" (German, Indian, Swiss Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,507, issued on Feb. 24, was assigned to BASF SE (Ludwigshafen, Germany).

"Method for preparing an enantiomerically enriched form of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-ajpyrimidin-4-ium-5-olate" was invented by Christopher Koradin (Ludwigshafen, Germany), Martin John McLaughlin (Liestal, Switzerland), Harish Shinde (Navi Mumbai, India), Rahul Kaduskar (Navi Mumbai, India), Roland Goetz (Ludwigshafen, Germany) and Guillaume Michel Jacques Garivet (Ludwigshafen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for preparing an enantiomerically enriched form of 3-(2-ch...